Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China

BACKGROUND: The prevalence of hepatitis B virus (HBV) infection is high among individuals infected with human immunodeficiency virus (HIV) in China. Both HIV and HBV can be treated with tenofovir disoproxil fumarate (TDF) and lamivudine (3TC), so we evaluated the safety and efficacy of combination a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ya-Song, Zhang, Wei-Wei, Ling, Xue-Mei, Yang, Lian, Huang, Shao-Biao, Wang, Xi-Cheng, Wu, Hao, Cai, Wei-Ping, Wang, Min, Wang, Hui, Liu, Yan-Fen, He, Hao-Lan, Wei, Fei-Li, Wu, Zun-You, Zhang, Fu-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799574/
https://www.ncbi.nlm.nih.gov/pubmed/26831232
http://dx.doi.org/10.4103/0366-6999.174509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799574/
https://www.ncbi.nlm.nih.gov/pubmed/26831232
http://dx.doi.org/10.4103/0366-6999.174509

Ejemplares similares